Regen Med Res
Volume 2, 2014
|Number of page(s)||3|
|Published online||05 February 2014|
Human induced pluripotent stem cell for modeling cardiovascular diseases
Beijing Anzhen Hospital, Capital Medical University, Beijing, China
2 The key laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Capital Medical University, Beijing, China
3 Beijing Institute of Heart Lung & Blood Vessel Disease, Beijing, China
4 Department of Medicine, Division of Cardiology, Stanford University, Stanford, CA, USA
5 Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA
6 Cardiovascular Institute, Stanford University, Stanford, CA, USA
7 Lorry I. Lokey Stem Cell Research Building, Rm G1105, 265 Campus Drive, Stanford, CA 94305, USA
* Correspondence: firstname.lastname@example.org
Received: 1 August 2013
Accepted: 6 November 2013
The invention of the induced pluripotent stem cell (iPSC) technology allows patient-specific, mature somatic cells to be converted into an unlimited supply of pluripotent stem cells (PSCs). These iPSCs can then in turn be differentiated into any cell type including neurons, cardiac cells, pancreatic cells, liver cells, blood cells or enterocytes. Although cardiovascular disease (CVD) is a leading cause of death in the world, the limited cell derivation and cell number in cardiac tissue makes it difficult to study the CVDs using the existing cardiac cell model. By differentiating the patient-specific iPSCs into cardiomyocytes, scientists can generate iPSC-based ‘disease in a dish’ models and use them to better understand disease mechanism. Here we review the current progress in using iPSC-derived cardiomyocytes to model human CVDs.
Key words: Stem cells / Induced pluripotent stem cells / Cardiovascular disease / Disease modeling
© 2014 Liang and Du; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.